Approximately 8% of Canadian adults will experience major depression at some time in their lives. It’s the leading cause of disability worldwide with high unmet need.
Achieving response and remission with treatment in major depressive disorder (MDD) requires time and effort, prolonging patient suffering. Treatment has changed very little over 30 years.
We’re using emerging science to develop novel therapies for the treatment of severe mood disorders.